LNC Therapeutics raises EUR6.5m
LNC Therapeutics, a company specialising in the research and development of gut microbiota directed drugs for the treatment of obesity and associated cardiometabolic diseases, has closed a EUR6.5 million C series funding round. This new round, co-led by Seventure Partner, brings together a consortium of historic investors and a family